John T said...
One thing that I learned is that most advice given on Brachy from most doctors who are not Brachytherapists is most likely wrong. I like a few others on this forum were told that Brachy was not suitable in our cases. This information was wrong just as the information that anything over G6 is not suitiable for Brachy. The evidence is very clear in the fact that Brachy alone is effective across all Gleason Grades.
The following are results from 12 instutitions on their surgical cure rates compared to 24 institutions using seeds:
Low risk: surgery 85%; Brachy 95%
Intermediate risk: surgery 70%, brachy 85%
High risk: surgery 40%; Brachy 75%
This does not indicate that Brachy is ineffective for intermediate or high risk cases as many doctors would have us believe.
If a patient wants advice on seeds he should go to an experienced Brachytherapist and be very careful of the advice given by a non Brachy doctor.
JohnT
Great post John......and in all fairness, sometimes the information can be misleading. The following was taken from my own procedure that I have been posting:
). Who Is Eligible For Seed Implant? Over the past decade
brachytherapy has become an increasingly popular treatment for the early
stages of prostate cancer. But it's generally used only for small,
favourable risk cancers (low grade, low stage, low PSA) that have a high
likelihood of being confined to the prostate or immediate surrounding
area. For these patients, a permanent seed implant will be the only
treatment needed. Evidence-based guidelines recommend that this form of
treatment be applied as the only treatment to those men with: T1c/T2a
tumour, which either isn’t palpable (felt) on rectal exam, or is
palpable as a small nodule Gleason score less than or equal to 6 PSA
less than 10 ng/mL
Outside these criteria, there is a greater risk that prostate cancer
cells have spread into tissue surrounding the prostate outside the
implant margin. Because radioactive seed implants have a short range,
some tumour cells located outside the prostate may not
receive a sufficient dose to be eradicated. These men with more
aggressive cancers may be suitable for a combination of external beam
and implant (seeds or HDR).